Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes.

Vaccines

Hein S, Benz NI, Eisert J, Herrlein ML, Oberle D, Dreher M, Stingl JC, Hildt C, Hildt E.
PMID: 34960165
Vaccines (Basel). 2021 Dec 01;9(12). doi: 10.3390/vaccines9121419.

Many of the approved SARS-CoV-2 vaccines are based on a stabilized variant of the spike protein. This raises the question of whether the immune response against the stabilized spike is identical to the immune response that is elicited by...

Cite
Hein S, Benz NI, Eisert J, et al. Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes. Vaccines (Basel). 2021;9(12)doi: 10.3390/vaccines9121419.
Hein, S., Benz, N. I., Eisert, J., Herrlein, M. L., Oberle, D., Dreher, M., Stingl, J. C., Hildt, C., & Hildt, E. (2021). Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes. Vaccines, 9(12), . https://doi.org/10.3390/vaccines9121419
Hein, Sascha, et al. "Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes." Vaccines vol. 9,12 (2021). doi: https://doi.org/10.3390/vaccines9121419
Hein S, Benz NI, Eisert J, Herrlein ML, Oberle D, Dreher M, Stingl JC, Hildt C, Hildt E. Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes. Vaccines (Basel). 2021 Dec 01;9(12). doi: 10.3390/vaccines9121419. PMID: 34960165.
Copy Download .nbib Format: NLM
A Framework for Regional Agroecosystems Characterization Using the National Resources Inventory.

Journal of environmental quality

Burkart MR, Oberle SL, Hewitt MJ, Pickus J.
PMID: 34872210
J Environ Qual. 1994 Sep;23(5):866-874. doi: 10.2134/jeq1994.00472425002300050002x.

An agroecological framework is used to examine the relations among natural resources and agriculture. Spatial representation of selected agroecosystems characteristics was accomplished using the National Resources Inventory (NRI). Natural resource and anthropogenic variables from the NRI were spatially aggregated...

Cite
Burkart MR, Oberle SL, Hewitt MJ, et al. A Framework for Regional Agroecosystems Characterization Using the National Resources Inventory. J Environ Qual. 1994;23(5):866-874doi: 10.2134/jeq1994.00472425002300050002x.
Burkart, M. R., Oberle, S. L., Hewitt, M. J., & Pickus, J. (1994). A Framework for Regional Agroecosystems Characterization Using the National Resources Inventory. Journal of environmental quality, 23(5), 866-874. https://doi.org/10.2134/jeq1994.00472425002300050002x
Burkart, M R, et al. "A Framework for Regional Agroecosystems Characterization Using the National Resources Inventory." Journal of environmental quality vol. 23,5 (1994): 866-874. doi: https://doi.org/10.2134/jeq1994.00472425002300050002x
Burkart MR, Oberle SL, Hewitt MJ, Pickus J. A Framework for Regional Agroecosystems Characterization Using the National Resources Inventory. J Environ Qual. 1994 Sep;23(5):866-874. doi: 10.2134/jeq1994.00472425002300050002x. PMID: 34872210.
Copy Download .nbib Format: NLM
Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Müller S, Oberle D, Drechsel-Bäuerle U, Pavel J, Keller-Stanislawski B, Funk MB.
PMID: 30498414
Transfus Med Hemother. 2018 Oct;45(5):355-367. doi: 10.1159/000481994. Epub 2018 Feb 28.

BACKGROUND: Benefits and risks of liberal and restrictive transfusion regimens are under on-going controversial discussion. This systematic review aimed at assessing both regimens in terms of pre-defined outcomes with special focus on patients undergoing major orthopaedic surgery.METHODS: We performed...

Cite
Müller S, Oberle D, Drechsel-Bäuerle U, et al. Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review. Transfus Med Hemother. 2018;45(5):355-367doi: 10.1159/000481994.
Müller, S., Oberle, D., Drechsel-Bäuerle, U., Pavel, J., Keller-Stanislawski, B., & Funk, M. B. (2018). Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 45(5), 355-367. https://doi.org/10.1159/000481994
Müller, Susanne, et al. "Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 45,5 (2018): 355-367. doi: https://doi.org/10.1159/000481994
Müller S, Oberle D, Drechsel-Bäuerle U, Pavel J, Keller-Stanislawski B, Funk MB. Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review. Transfus Med Hemother. 2018 Oct;45(5):355-367. doi: 10.1159/000481994. Epub 2018 Feb 28. PMID: 30498414; PMCID: PMC6257151.
Copy Download .nbib Format: NLM
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes.

Vaccines

Hein S, Benz NI, Eisert J, Herrlein ML, Oberle D, Dreher M, Stingl JC, Hildt C, Hildt E.
PMID: 34960165
Vaccines (Basel). 2021 Dec 01;9(12). doi: 10.3390/vaccines9121419.

Many of the approved SARS-CoV-2 vaccines are based on a stabilized variant of the spike protein. This raises the question of whether the immune response against the stabilized spike is identical to the immune response that is elicited by...

Cite
Hein S, Benz NI, Eisert J, et al. Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes. Vaccines (Basel). 2021;9(12)doi: 10.3390/vaccines9121419.
Hein, S., Benz, N. I., Eisert, J., Herrlein, M. L., Oberle, D., Dreher, M., Stingl, J. C., Hildt, C., & Hildt, E. (2021). Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes. Vaccines, 9(12), . https://doi.org/10.3390/vaccines9121419
Hein, Sascha, et al. "Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes." Vaccines vol. 9,12 (2021). doi: https://doi.org/10.3390/vaccines9121419
Hein S, Benz NI, Eisert J, Herrlein ML, Oberle D, Dreher M, Stingl JC, Hildt C, Hildt E. Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes. Vaccines (Basel). 2021 Dec 01;9(12). doi: 10.3390/vaccines9121419. PMID: 34960165; PMCID: PMC8708883.
Copy Download .nbib Format: NLM
Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.

Allergy

Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski B, Herrlein ML, Maier TJ, Hildt E.
PMID: 34637150
Allergy. 2021 Oct 12; doi: 10.1111/all.15138. Epub 2021 Oct 12.

BACKGROUND: People suffering from COVID-19 are typically considered non-infectious 14 days after diagnosis if symptoms have disappeared for at least 48 h. We describe three patients who independently acquired their infection. These three patients experienced mild COVID-19 and completely...

Cite
Zahn T, Mhedhbi I, Hein S, et al. Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19. Allergy. 2021;doi: 10.1111/all.15138.
Zahn, T., Mhedhbi, I., Hein, S., Raupach, J., Miskey, C., Husria, Y., Bayanga, K., Bartel, D., Vieths, S., Ivics, Z., Oberle, D., Keller-Stanislawski, B., Herrlein, M. L., Maier, T. J., & Hildt, E. (2021). Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19. Allergy, . https://doi.org/10.1111/all.15138
Zahn, Tobias, et al. "Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19." Allergy vol. (2021). doi: https://doi.org/10.1111/all.15138
Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski B, Herrlein ML, Maier TJ, Hildt E. Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19. Allergy. 2021 Oct 12; doi: 10.1111/all.15138. Epub 2021 Oct 12. PMID: 34637150; PMCID: PMC8652783.
Copy Download .nbib Format: NLM
Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses.

Allergy

Hein S, Herrlein ML, Mhedhbi I, Bender D, Haberger V, Benz N, Eisert J, Stingl J, Dreher M, Oberle D, Schulze J, Mache C, Budt M, Hildt C, Wolff T, Hildt E.
PMID: 34820854
Allergy. 2021 Nov 25; doi: 10.1111/all.15189. Epub 2021 Nov 25.

BACKGROUND: The mRNA vaccine BNT162b2 (Comirnaty, BioNTech/Pfizer) and the vaccine candidate CVnCoV (Curevac) each encode a stabilized spike protein of SARS-CoV2 as antigen but differ with respect to the nature of the mRNA (modified versus unmodified nucleotides) and the...

Cite
Hein S, Herrlein ML, Mhedhbi I, et al. Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses. Allergy. 2021;doi: 10.1111/all.15189.
Hein, S., Herrlein, M. L., Mhedhbi, I., Bender, D., Haberger, V., Benz, N., Eisert, J., Stingl, J., Dreher, M., Oberle, D., Schulze, J., Mache, C., Budt, M., Hildt, C., Wolff, T., & Hildt, E. (2021). Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses. Allergy, . https://doi.org/10.1111/all.15189
Hein, Sascha, et al. "Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses." Allergy vol. (2021). doi: https://doi.org/10.1111/all.15189
Hein S, Herrlein ML, Mhedhbi I, Bender D, Haberger V, Benz N, Eisert J, Stingl J, Dreher M, Oberle D, Schulze J, Mache C, Budt M, Hildt C, Wolff T, Hildt E. Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses. Allergy. 2021 Nov 25; doi: 10.1111/all.15189. Epub 2021 Nov 25. PMID: 34820854.
Copy Download .nbib Format: NLM
Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018).

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Orru' S, Poetzsch K, Hoffelner M, Heiden M, Funk MB, Keller-Stanislawski B, Oberle D.
PMID: 34803571
Transfus Med Hemother. 2021 Mar 31;48(5):272-283. doi: 10.1159/000516049. eCollection 2021 Oct.

INTRODUCTION: According to German legislation, reports of suspected serious adverse reactions (AR) associated with the donation of blood and its components are continuously being evaluated by the Paul-Ehrlich-Institut. This survey aimed at providing a more complete picture of the...

Cite
Orru' S, Poetzsch K, Hoffelner M, et al. Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018). Transfus Med Hemother. 2021;48(5):272-283doi: 10.1159/000516049.
Orru', S., Poetzsch, K., Hoffelner, M., Heiden, M., Funk, M. B., Keller-Stanislawski, B., & Oberle, D. (2021). Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018). Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 48(5), 272-283. https://doi.org/10.1159/000516049
Orru', Stefano, et al. "Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018)." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 48,5 (2021): 272-283. doi: https://doi.org/10.1159/000516049
Orru' S, Poetzsch K, Hoffelner M, Heiden M, Funk MB, Keller-Stanislawski B, Oberle D. Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018). Transfus Med Hemother. 2021 Mar 31;48(5):272-283. doi: 10.1159/000516049. eCollection 2021 Oct. PMID: 34803571; PMCID: PMC8578804.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries